Products
Platform
Research
Market
Learn
Senores Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 178.34 | 167.17 | 141.35 | 125.98 | 108.18 |
| Other Income Qtr Cr | 3.78 | 5.41 | 3.36 | 11.77 | 5.16 |
| Operating Revenues Qtr | 174.56 | 161.76 | 137.99 | 114.21 | 103.02 |
Loading chart... | |||||
Operating Expenses Qtr | 120.55 | 112.26 | 103.83 | 94.77 | 77.33 |
Operating Profit Qtr | 54.01 | 49.50 | 34.16 | 19.44 | 25.69 |
EBITDA Qtr Cr | 57.79 | 54.91 | 37.52 | 31.21 | 30.85 |
Depreciation Qtr | 7.86 | 8.09 | 5.99 | 5.23 | 4.20 |
Net Profit Qtr | 31.66 | 32.38 | 19.73 | 17.83 | 17.18 |
Basic EPS Qtr | 7.29 | 6.54 | 4.60 | 3.81 | 5.04 |
Open Demat Account
Open Demat Account